Biocept (BIOC) Reports Q2 Loss of $0.38/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts BIOC Hot Sheet
Join SI Premium – FREE
Biocept (NASDAQ: BIOC) reported Q2 EPS of ($0.38), versus ($0.05) reported last year. Revenue for the quarter came in at $1.2 million, versus $917.5 thousand reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Highlights Top Shopping Center REITs Ahead of Q3 Earnings
- Bloom Energy Corp. (BE) PT Raised to $306 at Bernstein SocGen After a 'Strong beat and raise'
- New Street bullish on Intel to Buy as CPU scarcity strengthens turnaround
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
